PRTC
PureTech Health plc
NASDAQ · Healthcare · Biotechnology · US
$17.38
+2.12%Margins
Gross margin
-471.2%
EBITDA margin
-2043.5%
EBIT margin
-2115.4%
Net margin
-2355.5%
FCF margin
-1824.6%
-35.1%
Return on equity
-20.5%
Return on assets
-29.6%
Return on invested capital
0.01x
Asset turnover
-$84.8M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025